175 related articles for article (PubMed ID: 35363406)
21. Downregulated Expression of RIPOR3 Correlated with Immune Infiltrates Predicts Poor Prognosis in Oral Tongue Cancer.
Zhang K; Da J; Liu X; Liu X; Wang J; Jin H; Li Y; Zhang B
Med Sci Monit; 2022 Mar; 28():e935055. PubMed ID: 35277469
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of FOXD1 is associated with cervical node metastasis and unfavorable prognosis in oral squamous cell carcinoma.
Li Z; Yan T; Wu X; Zhang W; Li J; Wang L; Yang J
J Oral Pathol Med; 2020 Nov; 49(10):1030-1036. PubMed ID: 32808339
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of Myosin 6 inhibits proliferation of oral squamous cell carcinoma cells.
Zhang X; Huang Z; Hu Y; Liu L
J Oral Pathol Med; 2016 Nov; 45(10):740-745. PubMed ID: 27561828
[TBL] [Abstract][Full Text] [Related]
24. A Minimal DNA Methylation Signature in Oral Tongue Squamous Cell Carcinoma Links Altered Methylation with Tumor Attributes.
Krishnan NM; Dhas K; Nair J; Palve V; Bagwan J; Siddappa G; Suresh A; Kekatpure VD; Kuriakose MA; Panda B
Mol Cancer Res; 2016 Sep; 14(9):805-19. PubMed ID: 27288358
[TBL] [Abstract][Full Text] [Related]
25. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
26. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813
[TBL] [Abstract][Full Text] [Related]
27. Metallothionein gene expression is altered in oral cancer and may predict metastasis and patient outcomes.
Brazão-Silva MT; Rodrigues MF; Eisenberg AL; Dias FL; de Castro LM; Nunes FD; Faria PR; Cardoso SV; Loyola AM; de Sousa SC
Histopathology; 2015 Sep; 67(3):358-67. PubMed ID: 25640883
[TBL] [Abstract][Full Text] [Related]
28. EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma.
Liu L; Wang X; Ge W
Med Sci Monit; 2018 Oct; 24():7213-7222. PubMed ID: 30300334
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of Synuclein-
Yang J; Pan Y; Peng L; Zhang L; Zhao J; Zheng Z; Zheng J; Xu X; Zeng Y
Biomed Res Int; 2022; 2022():6534626. PubMed ID: 35434126
[TBL] [Abstract][Full Text] [Related]
30. Decreased expression of Beclin‑1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma.
Hu Z; Zhong Z; Huang S; Wen H; Chen X; Chu H; Li Q; Sun C
Mol Med Rep; 2016 Aug; 14(2):1567-73. PubMed ID: 27356955
[TBL] [Abstract][Full Text] [Related]
31. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
Kauppila JH; Korvala J; Siirilä K; Manni M; Mäkinen LK; Hagström J; Atula T; Haglund C; Selander KS; Saarnio J; Karttunen TJ; Lehenkari PP; Salo T
J Oral Pathol Med; 2015 Sep; 44(8):571-7. PubMed ID: 25338738
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of tertiary lymphoid structures in early clinical stage oral tongue squamous cell carcinoma.
Wang C; Huang Z; Zhang M; Xiong G; Chen X; Xie N
J Oral Pathol Med; 2021 Sep; 50(8):776-784. PubMed ID: 34124806
[TBL] [Abstract][Full Text] [Related]
33. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
Clauditz TS; Wang CJ; Gontarewicz A; Blessmann M; Tennstedt P; Borgmann K; Tribius S; Sauter G; Dalchow C; Knecht R; Münscher A; Wilczak W
J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
[TBL] [Abstract][Full Text] [Related]
34. Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis.
da Silva SD; Marchi FA; Xu B; Bijian K; Alobaid F; Mlynarek A; Rogatto SR; Hier M; Kowalski LP; Alaoui-Jamali MA
Oncotarget; 2015 Sep; 6(26):21950-63. PubMed ID: 26110570
[TBL] [Abstract][Full Text] [Related]
35. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.
Zhao C; Zhou Y; Ma H; Wang J; Guo H; Liu H
BMC Oral Health; 2021 May; 21(1):232. PubMed ID: 33941139
[TBL] [Abstract][Full Text] [Related]
36. Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC).
Bu J; Bu X; Liu B; Chen F; Chen P
Med Sci Monit; 2015 Aug; 21():2275-81. PubMed ID: 26242444
[TBL] [Abstract][Full Text] [Related]
37. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
38. Expression of myeloid zinc finger 1 and the correlation to clinical aspects of oral squamous cell carcinoma.
Ko CP; Yang LC; Chen CJ; Yeh KT; Lin SH; Yang SF; Chen MK; Lin CW
Tumour Biol; 2015 Sep; 36(9):7099-105. PubMed ID: 25877752
[TBL] [Abstract][Full Text] [Related]
39. RIOK2 Contributes to Cell Growth and Protein Synthesis in Human Oral Squamous Cell Carcinoma.
Matsuzaki Y; Naito Y; Miura N; Mori T; Watabe Y; Yoshimoto S; Shibahara T; Takano M; Honda K
Curr Oncol; 2022 Dec; 30(1):381-391. PubMed ID: 36661680
[TBL] [Abstract][Full Text] [Related]
40. Squamous cell carcinomas of the tongue and oral cavity as secondary malignancies: what factors are implicated?
Muggia F
Oncologist; 2013; 18(3):245-7. PubMed ID: 23485623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]